Welcome to the Oncomine Blog
Healthcare Economic Analysis Makes Case for In-house NGS
08/07/2023 |
Education
Next-generation sequencing (NGS) has become an increasingly important tool for identifying molecular biomarkers that can help guide treatment...
-
Healthcare Economic Analysis Makes Case for In-house NGS
Next-generation sequencing (NGS) has become an increasingly important tool for identifying molecular... -
Clinical Utility of Frontline NGS for Myeloid Malignancies
In his recent talk at OncomineWorld 2023, Dr. Bekim Sadikovic presented a strong, evidence-based arg... -
Fusion detection in precision oncology, tradeoff decisions and genomic profiling democratization - An Interview with Dr. Eric Vail
Dr. Eric Vail is Director of Molecular Pathology, Cedars-Sinai Medical Center, Los Angeles, Californ... -
Leveraging Rapid NGS to Advance Hemato-Oncology Research
In a recent Association for Molecular Pathology (AMP) workshop, Dr. Cecilia Yeung shared how her lab... -
How to take advantage of the Oncomine Clinical Research Grant Program
What is the Oncomine Clinical Research Grant Program? The Oncomine Clinical Research Grant is a Ther... -
Improving Patient Access to Homologous Recombination Deficiency Testing for Precision Oncology
Introduction While next-generation sequencing (NGS) has enabled molecular characterization of tumors... -
Simplifying MDS Testing with Next-Generation Sequencing (NGS)
Myelodysplastic syndromes (MDS) are a heterogenous group of myeloid clonal disorders that are charac... -
Comprehensive Genomic Profiling (CGP): Accelerating Progress in Precision oncology
Comprehensive genomic profiling (CGP) is one of the latest innovations in next-generation sequencing... -
Genomic Profiling from Initial Assessment to Detection of Measurable Residual Disease (MRD): How NGS Can Rapidly Deliver Key Insights for Myeloid Neoplasms
In his recent webinar, Dr. Bevan Tandon makes a compelling case for how next-generation sequencing (...